Compound: idebenone
SMILES: O=C1C(OC)=C(OC)C(=O)C(=C1CCCCCCCCCCO)C
InChIKey: JGPMMRGNQUBGND-UHFFFAOYSA-N
Synonyms: idebenone, 58186-27-9, Idebenona, Raxone, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione, Idebenonum, Sovrima, CV 2619, hydroxydecyl ubiquinone, CV-2619, Oristar hdu, 2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinone, 6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone, DTXSID0040678, CHEBI:31687, HB6PN45W4J, NSC-759228, 2,5-Cyclohexadiene-1,4-dione, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-, 2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-p-benzoquinone, DTXCID8020678, 2,3-dimethoxy-5-methyl-6-(10'-hydroxydecyl)-1,4-benzoquinone, noben, 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-p-benzoquinone, RefChem:789668, N06BX13, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, BRN 2001459, MFCD00274552, 2-(10-hydroxydecyl)-6-methoxy-3-methyl-5-(trideuteriomethoxy)cyclohexa-2,5-diene-1,4-dione, 5,6-DIMETHOXY-2-(10-HYDROXYDECYL)-3-METHYL-1,4-BENZOQUINONE, NCGC00160514-01, 2,3-Dimethoxy-6-(10-hydroxydecyl)-5-methyl-1,4-benzoquinone, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylbenzo-1,4-quinone, Idebenone [INN:JAN], Idebenonum [Latin], Idebenona [Spanish], Avan, SMR000466364, CAS-58186-27-9, SR-01000759378, UNII-HB6PN45W4J, Cerestabon, Nemocebral, Catena, Mnesis, Cerestabon;, Geniceral;, Lucenabol;, Daruma;, Esanic;, Idesol;, Mnesis;, Avan;, Raxone (TN), Idebenone (Standard), IDEBENONE [INN], IDEBENONE [JAN], IDEBENONE [MI], IDEBENONE [USAN], Epitope ID:969010, IDEBENONE [MART.], IDEBENONE [WHO-DD], SNT-MC17, SCHEMBL28320, IDEBENONE [EMA EPAR], Idebenone (JAN/USAN/INN), MLS000759487, MLS001032035, MLS001424002, MLS006011882, Idebenone, analytical standard, Idebenone - Bio-X trade mark, CHEMBL252556, orb1310640, QSA-10, Idebenone, >=98% (HPLC), HY-N0303R, FR114, GLXC-02503, HMS2051O06, HMS2089D08, HMS3393O06, HMS3656K22, HMS3713A10, HMS3884B12, HMS5081P09, HMS6019L05, Pharmakon1600-01505755, ALBB-027258, HY-N0303, MSK11181, PXB90775, STR09227, Tox21_111864, BBL025842, BDBM50505498, EBC-15034, NSC759228, s2605, STK801942, 2,5-Cyclohexadiene-1,4-dione, 5,6-dimethoxy-2-(10-hydroxydecyl)-3-methyl-, 2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-cyclohexa-2,5-diene-1,4-dione, AKOS005622577, Tox21_111864_1, AC-4337, CCG-100846, FH24537, KS-5193, NC00096, NSC 759228, SB19130, NCGC00160514-02, NCGC00160514-03, BI164565, SY051193, SBI-0207024.P001, DB-053168, I0848, SW219495-1, D01750, H10427, AB00639997-04, AB00639997-06, AB00639997_07, AB00639997_08, EN300-7359600, A-68500, Q4197874, SR-01000759378-4, SR-01000759378-5, SR-01000759378-6, BRD-K37516142-001-01-4, BRD-K37516142-001-09-7, BRD-K37516142-001-10-5, BRD-K37516142-001-11-3, 2,3-Dimethoxy-6-(10-hydroxydecyl)-5-methylbenzoquinone, Z2216898922, 2,3-Dimethoxy-6-(10-hydroxydecyl)-5-methyl-1,4benzoquinone, 2-(10-Hydroxydecyl)-5,6-methoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 2-  (10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-cyclohexa-2,5-diene-1,4-dione
Theoretical properties:
molecular_formula: C19H30O5
molecular_weight: 338.4 g/mol
exact_mass: 338.20932405 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 1
hydrogen_bond_acceptor_count: 5
rotatable_bond_count: 12
heavy_atom_count: 24
topological_polar_surface_area: 72.8 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: Idebenone is a member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. It has a role as a ferroptosis inhibitor and an antioxidant. It is a member of 1,4-benzoquinones and a primary alcohol.
chebi: A member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia.
chembl: IDEBENONE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Idebenone, sold under the brand name Raxone among others, is a medication that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success. The Swiss company Santhera Pharmaceuticals has started to investigate it for the treatment of neuromuscular diseases. In 2010, early clinical trials for the treatment of Friedreich's ataxia and Duchenne muscular dystrophy have been completed. As of December 2013 the drug is not approved for these indications in North America or Europe. It is approved by the European Medicines Agency (EMA) for use in Leber's hereditary optic neuropathy (LHON) and was designated an orphan drug in 2007.
Chemically, idebenone is an organic compound of the quinone family. It is also promoted commercially as a synthetic analog of coenzyme Q10 (CoQ10).